Mar
18
2010
Today the National Institutes of Health (NIH) announced its plans to create a public database in which genetic test providers will voluntarily deposit information about their services that can then be searched by researchers, consumers, health care providers, and others. The aim of this Genetic Testing Registry, which is expected to be [...]
Tags: Anne Wojcicki, Francis Collins, Genetic Testing Registry, NIH
Oct
28
2009
Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as the newer drug prasugrel (Effient™, Eli Lilly and Company) in people who lack a genetic variation that inhibits their metabolism of clopidogrel. This new research has [...]
Tags: clopidogrel, clotting, comparative effectiveness research, CYP2C19, Effient, Francis Collins, heart, Medco, pharmacogenomics, Plavix, prasugrel
Apr
16
2009
In 2005 two well-known human geneticists, Francis Collins and Thomas Gelehrter, made a bet: Collins wagered that by the 2008 American Society for Human Genetics meeting, genomewide association studies would have led to the discovery of at least four “validated – not just guessed at” susceptibility variants for at least five common diseases.
Collins won his [...]
Tags: David Goldstein, David Hunter, Francis Collins, genomewide association studies, Joel Hirschhorn, New England Journal of Medicine, Peter Kraft